Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
293
datasets available to search
ShareScore release 0.9.0
Dataset results
293 results for “PARP”
Pregabalin and Radicular Pain Study (PARPS)
ClinicalTrials.gov study NCT01061697. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers
ClinicalTrials.gov study NCT01776437. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer
ClinicalTrials.gov study NCT06572735. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
ClinicalTrials.gov study NCT05489926. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
ClinicalTrials.gov study NCT06544460. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy
ClinicalTrials.gov study NCT05295589. IPD Sharing: YES. Countries: 1. Publications: 0.
A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
ClinicalTrials.gov study NCT02127151. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy
ClinicalTrials.gov study NCT05255861. IPD Sharing: NO. Countries: 1. Publications: 0.
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SS
ClinicalTrials.gov study NCT06607692. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
ClinicalTrials.gov study NCT03562832. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03462342. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
ClinicalTrials.gov study NCT06588322. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
ClinicalTrials.gov study NCT03911453. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients
ClinicalTrials.gov study NCT05320757. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, B
ClinicalTrials.gov study NCT06130254. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
ClinicalTrials.gov study NCT05700721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor
ClinicalTrials.gov study NCT05475184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
ClinicalTrials.gov study NCT03492164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
ClinicalTrials.gov study NCT05065021. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours
ClinicalTrials.gov study NCT00633269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.